| class name | count |
|---|
| class name | count |
|---|---|
| Streptomycetaceae | 13 |
| Thermomonosporaceae | 4 |
| Micromonosporaceae | 2 |
| br08003 Category | # of metabolite |
|---|
| br08003 Category | KEGG ID | KNApSAcK ID |
|---|
| KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
figure |
|---|---|---|---|---|---|---|
|
C00016728
|
Rubomycin F
|
C076482
|
|
|||
|
C00016729
|
NSC 143113
/ Rubomycin H / N-Carboxydaunorubicin methyl ester |
C076483
|
|
|||
|
C00016816
|
TAN 1120
|
C081412
|
|
|||
|
C00018142
|
Baumycin A1
|
C015018
|
|
|||
|
C00018143
|
Baumycin A2
|
|
||||
|
C00018144
|
Baumycin B1
|
|
||||
|
C00018145
|
Baumycin B2
|
|
||||
|
C00018146
|
NSC 227012
/ Baumycin C1 / N-Formyldaunorubicin |
|
||||
|
C00018147
|
Baumycin C2
|
|
||||
|
C00018317
|
11-Deoxydoxorubicin
|
C042239
|
|
|||
|
C00018318
|
11-Deoxydaunorubicin
|
|
||||
|
C00018343
|
Feudomycin A
/ 13-Deoxydaunomycin / 13-Deoxydaunorubicin |
C031980
|
|
|||
|
C00018344
|
Feudomycin B
|
C031981
|
|
|||
|
C00018351
|
Rubeomycin A
/ Antibiotic FA 1180A |
|
||||
|
C00018352
|
Rubeomycin A1
/ Antibiotic FA 1180A1 |
|
||||
|
C00018353
|
Rubeomycin B
/ Antibiotic FA 1180B |
C033381
|
|
|||
|
C00018354
|
Rubeomycin B1
/ Antibiotic FA 1180B1 |
|
||||
|
C00018406
|
4-O-Demethyl-11-deoxydoxorubicin
|
C034619
|
|
|||
|
C00043440
|
Daunomycin
/ Rubomycin C |
CHEMBL9659
CHEMBL178 CHEMBL1197788 CHEMBL1525753 CHEMBL1617377 |
D003630
|
136 / 91 / 85 | 121 / 95 |
|
| accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
|---|---|---|---|---|
| P14550 | Alcohol dehydrogenase [NADP(+)] | Enzyme | C00043440 | 0 / 0 |
| P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00043440 | 1 / 0 |
| P33527 | Multidrug resistance-associated protein 1 | drugs | C00043440 | 0 / 0 |
| P04637 | Cellular tumor antigen p53 | Transcription Factor | C00043440 | 7 / 37 |
| Q16637 | Survival motor neuron protein | Unclassified protein | C00043440 | 4 / 1 |
| Q99700 | Ataxin-2 | Unclassified protein | C00043440 | 1 / 1 |
| O95342 | Bile salt export pump | drug | C00043440 | 2 / 1 |
| P21728 | D(1A) dopamine receptor | Dopamine receptor | C00043440 | 0 / 0 |
| P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00043440 | 0 / 3 |
| Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00043440 | 2 / 2 |
| P08246 | Neutrophil elastase | S1A | C00043440 | 2 / 1 |
| P33765 | Adenosine receptor A3 | Adenosine receptor | C00043440 | 0 / 0 |
| Q16539 | Mitogen-activated protein kinase 14 | p38 | C00043440 | 0 / 0 |
| P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00043440 | 0 / 0 |
| P29466 | Caspase-1 | C14 | C00043440 | 0 / 0 |
| P17252 | Protein kinase C alpha type | Alpha | C00043440 | 0 / 0 |
| P27361 | Mitogen-activated protein kinase 3 | Erk | C00043440 | 0 / 0 |
| P14780 | Matrix metalloproteinase-9 | M10A | C00043440 | 2 / 2 |
| Q13547 | Histone deacetylase 1 | Hydrolase | C00043440 | 0 / 0 |
| O75604 | Ubiquitin carboxyl-terminal hydrolase 2 | Enzyme | C00043440 | 0 / 0 |
| P10828 | Thyroid hormone receptor beta | NR1A2 | C00043440 | 3 / 1 |
| P00918 | Carbonic anhydrase 2 | Lyase | C00043440 | 1 / 2 |
| P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00043440 | 0 / 1 |
| P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00043440 | 1 / 1 |
| P25021 | Histamine H2 receptor | Histamine receptor | C00043440 | 0 / 0 |
| P35367 | Histamine H1 receptor | Histamine receptor | C00043440 | 0 / 0 |
| Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00043440 | 1 / 0 |
| P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00043440 | 0 / 0 |
| P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00043440 | 0 / 0 |
| P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00043440 | 0 / 0 |
| Q9BY41 | Histone deacetylase 8 | Hydrolase | C00043440 | 2 / 0 |
| P08183 | Multidrug resistance protein 1 | drug | C00043440 | 1 / 0 |
| P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00043440 | 0 / 0 |
| P06241 | Tyrosine-protein kinase Fyn | Src | C00043440 | 0 / 0 |
| Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00043440 | 0 / 0 |
| P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00043440 | 0 / 1 |
| P54132 | Bloom syndrome protein | Enzyme | C00043440 | 1 / 2 |
| P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00043440 | 1 / 8 |
| P11387 | DNA topoisomerase 1 | Isomerase | C00043440 | 0 / 0 |
| P11388 | DNA topoisomerase 2-alpha | Isomerase | C00043440 | 0 / 0 |
| P11473 | Vitamin D3 receptor | NR1I1 | C00043440 | 2 / 3 |
| P14416 | D(2) dopamine receptor | Dopamine receptor | C00043440 | 2 / 0 |
| P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00043440 | 0 / 0 |
| P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00043440 | 0 / 0 |
| P41145 | Kappa-type opioid receptor | Opioid receptor | C00043440 | 0 / 0 |
| Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00043440 | 0 / 0 |
| P29274 | Adenosine receptor A2a | Adenosine receptor | C00043440 | 0 / 0 |
| P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00043440 | 0 / 0 |
| P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00043440 | 1 / 1 |
| O15296 | Arachidonate 15-lipoxygenase B | Enzyme | C00043440 | 0 / 0 |
| P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00043440 | 0 / 0 |
| P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00043440 | 1 / 0 |
| P00352 | Retinal dehydrogenase 1 | Enzyme | C00043440 | 0 / 0 |
| P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00043440 | 0 / 0 |
| Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | C00043440 | 0 / 0 |
| Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00043440 | 0 / 0 |
| P42858 | Huntingtin | Unclassified protein | C00043440 | 1 / 1 |
| P16152 | Carbonyl reductase [NADPH] 1 | Enzyme | C00043440 | 0 / 0 |
| O75496 | Geminin | Unclassified protein | C00043440 | 0 / 0 |
| O60656 | UDP-glucuronosyltransferase 1-9 | Enzyme | C00043440 | 0 / 0 |
| P38398 | Breast cancer type 1 susceptibility protein | Enzyme | C00043440 | 4 / 2 |
| P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00043440 | 0 / 0 |
| P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00043440 | 0 / 0 |
| P21917 | D(4) dopamine receptor | Dopamine receptor | C00043440 | 0 / 0 |
| P30988 | Calcitonin receptor | Calcitonin receptor | C00043440 | 0 / 0 |
| P35462 | D(3) dopamine receptor | Dopamine receptor | C00043440 | 1 / 0 |
| P41143 | Delta-type opioid receptor | Opioid receptor | C00043440 | 0 / 0 |
| Q92731 | Estrogen receptor beta | NR3A2 | C00043440 | 0 / 1 |
| P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00043440 | 0 / 0 |
| P25101 | Endothelin-1 receptor | Endothelin receptor | C00043440 | 0 / 0 |
| P30411 | B2 bradykinin receptor | Bradykinin receptor | C00043440 | 0 / 0 |
| P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00043440 | 1 / 0 |
| P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00043440 | 0 / 0 |
| P08311 | Cathepsin G | S1A | C00043440 | 0 / 0 |
| Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00043440 | 1 / 0 |
| P03956 | Interstitial collagenase | M10A | C00043440 | 0 / 1 |
| P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00043440 | 0 / 0 |
| Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00043440 | 1 / 2 |
| O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00043440 | 0 / 0 |
| P04150 | Glucocorticoid receptor | NR3C1 | C00043440 | 0 / 1 |
| P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00043440 | 2 / 0 |
| P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00043440 | 0 / 0 |
| P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00043440 | 0 / 0 |
| P31645 | Sodium-dependent serotonin transporter | Serotonin | C00043440 | 2 / 0 |
| P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00043440 | 5 / 9 |
| P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00043440 | 1 / 0 |
| P21452 | Substance-K receptor | Neurokinin receptor | C00043440 | 0 / 0 |
| P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00043440 | 0 / 0 |
| P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00043440 | 3 / 0 |
| P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00043440 | 0 / 0 |
| P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00043440 | 1 / 0 |
| P28482 | Mitogen-activated protein kinase 1 | Erk | C00043440 | 0 / 0 |
| P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00043440 | 2 / 1 |
| P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00043440 | 0 / 0 |
| P08253 | 72 kDa type IV collagenase | M10A | C00043440 | 1 / 3 |
| Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00043440 | 3 / 3 |
| Q9UNQ0 | ATP-binding cassette sub-family G member 2 | ATP binding cassette | C00043440 | 2 / 0 |
| Q92887 | Canalicular multispecific organic anion transporter 1 | Unclassified protein | C00043440 | 1 / 1 |
| O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00043440 | 0 / 0 |
| P03372 | Estrogen receptor | NR3A1 | C00043440 | 1 / 1 |
| P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00043440 | 1 / 0 |
| P22303 | Acetylcholinesterase | Hydrolase | C00043440 | 1 / 0 |
| P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00043440 | 0 / 0 |
| P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00043440 | 0 / 0 |
| P35372 | Mu-type opioid receptor | Opioid receptor | C00043440 | 0 / 0 |
| P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00043440 | 0 / 0 |
| P25103 | Substance-P receptor | Neurokinin receptor | C00043440 | 0 / 0 |
| P25105 | Platelet-activating factor receptor | PAF receptor | C00043440 | 0 / 0 |
| P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00043440 | 0 / 0 |
| P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00043440 | 1 / 1 |
| P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00043440 | 0 / 1 |
| P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00043440 | 0 / 0 |
| P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00043440 | 0 / 0 |
| P22309 | UDP-glucuronosyltransferase 1-1 | Enzyme | C00043440 | 5 / 1 |
| P10636 | Microtubule-associated protein tau | Unclassified protein | C00043440 | 4 / 3 |
| P19224 | UDP-glucuronosyltransferase 1-6 | Enzyme | C00043440 | 0 / 0 |
| P07477 | Trypsin-1 | S1A | C00043440 | 1 / 1 |
| P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00043440 | 1 / 1 |
| P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00043440 | 0 / 0 |
| P30542 | Adenosine receptor A1 | Adenosine receptor | C00043440 | 0 / 0 |
| P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00043440 | 0 / 0 |
| P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00043440 | 1 / 1 |
| P06239 | Tyrosine-protein kinase Lck | Src | C00043440 | 0 / 1 |
| P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00043440 | 0 / 0 |
| Q9UBN7 | Histone deacetylase 6 | Hydrolase | C00043440 | 0 / 0 |
| O14746 | Telomerase reverse transcriptase | Enzyme | C00043440 | 5 / 5 |
| Q9UBT6 | DNA polymerase kappa | Enzyme | C00043440 | 0 / 0 |
| B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00043440 | 0 / 0 |
| P46063 | ATP-dependent DNA helicase Q1 | Enzyme | C00043440 | 0 / 0 |
| Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00043440 | 0 / 0 |
| Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00043440 | 1 / 1 |
| O00255 | Menin | Unclassified protein | C00043440 | 2 / 5 |
| Q13951 | Core-binding factor subunit beta | Unclassified protein | C00043440 | 0 / 1 |
| Q01196 | Runt-related transcription factor 1 | Unclassified protein | C00043440 | 1 / 4 |
| O95255 | Multidrug resistance-associated protein 6 | Unclassified protein | C00043440 | 2 / 1 |
| Q92769 | Histone deacetylase 2 | Hydrolase | C00043440 | 0 / 0 |
| gene | gene name | gene description | KNApSAcK metabolite in interactions |
|---|---|---|---|
| 5243 | ABCB1, ABC20, CD243, CLCS, GP170, MDR1, P-GP, PGY1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) |
C00043440
|
| 18671 |
C00043440
|
||
| 4363 | ABCC1, ABC29, ABCC, GS-X, MRP, MRP1 | ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
C00043440
|
| 1244 | ABCC2, ABC30, CMOAT, DJS, MRP2, cMRP | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
C00043440
|
| 9429 | ABCG2, ABC15, ABCP, BCRP, BCRP1, BMDP, CD338, CDw338, EST157481, GOUT1, MRX, MXR, MXR1, UAQTL1 | ATP-binding cassette, sub-family G (WHITE), member 2 |
C00043440
|
| 25 | ABL1, ABL, JTK7, bcr/abl, c-ABL, p150, v-abl | c-abl oncogene 1, non-receptor tyrosine kinase (EC:2.7.10.2) |
C00043440
|
| 375790 | AGRN | agrin |
C00043440
|
| 10327 | AKR1A1, ALDR1, ALR, ARM, DD3 | aldo-keto reductase family 1, member A1 (aldehyde reductase) (EC:1.1.1.2) |
C00043440
|
| 231 | AKR1B1, ADR, ALDR1, ALR2, AR | aldo-keto reductase family 1, member B1 (aldose reductase) (EC:1.1.1.21) |
C00043440
|
| 57016 | AKR1B10, AKR1B11, AKR1B12, ALDRLn, ARL-1, ARL1, HIS, HSI | aldo-keto reductase family 1, member B10 (aldose reductase) (EC:1.1.1.2) |
C00043440
|
| 8644 | AKR1C3, DD3, DDX, HA1753, HAKRB, HAKRe, HSD17B5, PGFS, hluPGFS | aldo-keto reductase family 1, member C3 (EC:1.3.1.20 1.1.1.188 1.1.1.239 1.1.1.64 1.1.1.112 1.1.1.357) |
C00043440
|
| 207 | AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA | v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) |
C00043440
|
| 63982 | ANO3, C11orf25, DYT23, DYT24, TMEM16C | anoctamin 3 |
C00043440
|
| 302 | ANXA2, ANX2, ANX2L4, CAL1H, LIP2, LPC2, LPC2D, P36, PAP-IV | annexin A2 |
C00043440
|
| 307 | ANXA4, ANX4, PIG28, ZAP36 | annexin A4 |
C00043440
|
| 328 | APEX1, APE, APE1, APEN, APEX, APX, HAP1, REF1 | APEX nuclease (multifunctional DNA repair enzyme) 1 (EC:4.2.99.18) |
C00043440
|
| 472 | ATM, AT1, ATA, ATC, ATD, ATDC, ATE, TEL1, TELO1 | ataxia telangiectasia mutated (EC:2.7.11.1) |
C00043440
|
| 580 | BARD1 | BRCA1 associated RING domain 1 |
C00043440
|
| 581 | BAX, BCL2L4 | BCL2-associated X protein |
C00043440
|
| 596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00043440
|
| 637 | BID, FP497 | BH3 interacting domain death agonist |
C00043440
|
| 332 | BIRC5, API4, EPR-1 | baculoviral IAP repeat containing 5 |
C00043440
|
| 152940 | C4orf45 | chromosome 4 open reading frame 45 |
C00043440
|
| 51719 | CAB39, MO25 | calcium binding protein 39 |
C00043440
|
| 779 | CACNA1S, CACNL1A3, CCHL1A3, Cav1.1, HOKPP, HOKPP1, MHS5, TTPP1, hypoPP | calcium channel, voltage-dependent, L type, alpha 1S subunit |
C00043440
|
| 836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00043440
|
| 841 | CASP8, ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5 | caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) |
C00043440
|
| 847 | CAT | catalase (EC:1.11.1.6) |
C00043440
|
| 873 | CBR1, CBR, SDR21C1, hCBR1 | carbonyl reductase 1 (EC:1.1.1.189 1.1.1.197 1.1.1.184) |
C00043440
|
| 874 | CBR3, SDR21C2, hCBR3 | carbonyl reductase 3 (EC:1.1.1.184) |
C00043440
|
| 6347 | CCL2, GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, SCYA2, SMC-CF | chemokine (C-C motif) ligand 2 |
C00043440
|
| 6351 | CCL4, ACT2, AT744.1, G-26, HC21, LAG-1, LAG1, MIP-1-beta, MIP1B, MIP1B1, SCYA2, SCYA4 | chemokine (C-C motif) ligand 4 |
C00043440
|
| 896 | CCND3 | cyclin D3 |
C00043440
|
| 898 | CCNE1, CCNE | cyclin E1 |
C00043440
|
| 901 | CCNG2 | cyclin G2 |
C00043440
|
| 993 | CDC25A, CDC25A2 | cell division cycle 25A (EC:3.1.3.48) |
C00043440
|
| 1012 | CDH13, CDHH, P105 | cadherin 13 (EC:3.6.1.3) |
C00043440
|
| 1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
C00043440
|
| 1029 | CDKN2A, ARF, CDK4I, CDKN2, CMM2, INK4, INK4A, MLM, MTS-1, MTS1, P14, P14ARF, P16, P16-INK4A, P16INK4, P16INK4A, P19, P19ARF, TP16 | cyclin-dependent kinase inhibitor 2A |
C00043440
|
| 1030 | CDKN2B, CDK4I, INK4B, MTS2, P15, TP15, p15INK4b | cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
C00043440
|
| 634 | CEACAM1, BGP, BGP1, BGPI | carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) |
C00043440
|
| 10153 | CEBPZ, CBF, CBF2, HSP-CBF, NOC1 | CCAAT/enhancer binding protein (C/EBP), zeta |
C00043440
|
| 1196 | CLK2, hCLK2 | CDC-like kinase 2 (EC:2.7.12.1) |
C00043440
|
| 171425 | CLYBL, CLB | citrate lyase beta like |
C00043440
|
| 56942 | CMC2, 2310061C15Rik, C16orf61 | C-x(9)-C motif containing 2 |
C00043440
|
| 80790 | CMIP, TCMIP | c-Maf inducing protein |
C00043440
|
| 10283 | CWC27, NY-CO-10, SDCCAG10 | CWC27 spliceosome-associated protein homolog (S. cerevisiae) (EC:5.2.1.8) |
C00043440
|
| 1545 | CYP1B1, CP1B, CYPIB1, GLC3A, P4501B1 | cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) |
C00043440
|
| 1676 | DFFA, DFF-45, DFF1, ICAD | DNA fragmentation factor, 45kDa, alpha polypeptide |
C00043440
|
| 1875 | E2F5, E2F-5 | E2F transcription factor 5, p130-binding |
C00043440
|
| 1950 | EGF, HOMG4, URG | epidermal growth factor |
C00043440
|
| 9538 | EI24, EPG4, PIG8, TP53I8 | etoposide induced 2.4 |
C00043440
|
| 1978 | EIF4EBP1, 4E-BP1, 4EBP1, BP-1, PHAS-I | eukaryotic translation initiation factor 4E binding protein 1 |
C00043440
|
| 9852 | EPM2AIP1 | EPM2A (laforin) interacting protein 1 |
C00043440
|
| 2232 | FDXR, ADXR | ferredoxin reductase (EC:1.18.1.6) |
C00043440
|
| 202309 | GAPT, C5orf29 | GRB2-binding adaptor protein, transmembrane |
C00043440
|
| 2262 | GPC5 | glypican 5 |
C00043440
|
| 2944 | GSTM1, GST1, GSTM1-1, GSTM1a-1a, GSTM1b-1b, GTH4, GTM1, H-B, MU, MU-1 | glutathione S-transferase mu 1 (EC:2.5.1.18) |
C00043440
|
| 3184 | HNRNPD, AUF1, AUF1A, HNRPD, P37, hnRNPD0 | heterogeneous nuclear ribonucleoprotein D (AU-rich element RNA binding protein 1, 37kDa) |
C00043440
|
| 9641 | IKBKE, IKK-E, IKK-i, IKKE, IKKI | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon (EC:2.7.11.10) |
C00043440
|
| 3570 | IL6R, CD126, IL-6R-1, IL-6RA, IL6Q, IL6RA, IL6RQ, gp80 | interleukin 6 receptor |
C00043440
|
| 3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00043440
|
| 80895 | ILKAP, ILKAP2, ILKAP3, PP2C-DELTA | integrin-linked kinase-associated serine/threonine phosphatase (EC:3.1.3.16) |
C00043440
|
| 8821 | INPP4B | inositol polyphosphate-4-phosphatase, type II, 105kDa (EC:3.1.3.66) |
C00043440
|
| 547 | KIF1A, ATSV, C2orf20, HSN2C, MRD9, SPG30, UNC104 | kinesin family member 1A |
C00043440
|
| 4045 | LSAMP, IGLON3, LAMP | limbic system-associated membrane protein |
C00043440
|
| 338645 | LUZP2, KFSP2566, PRO6246 | leucine zipper protein 2 |
C00043440
|
| 4131 | MAP1B, FUTSCH, MAP5 | microtubule-associated protein 1B |
C00043440
|
| 5606 | MAP2K3, MAPKK3, MEK3, MKK3, PRKMK3, SAPKK-2, SAPKK2 | mitogen-activated protein kinase kinase 3 (EC:2.7.12.2) |
C00043440
|
| 4217 | MAP3K5, ASK1, MAPKKK5, MEKK5 | mitogen-activated protein kinase kinase kinase 5 (EC:2.7.11.25) |
C00043440
|
| 4137 | MAPT, DDPAC, FTDP-17, MAPTL, MSTD, MTBT1, MTBT2, PPND, TAU | microtubule-associated protein tau |
C00043440
|
| 4194 | MDM4, HDMX, MDMX, MRP1 | Mdm4 p53 binding protein homolog (mouse) |
C00043440
|
| 406991 | MIR21, MIRN21, hsa-mir-21, miR-21, miRNA21 | microRNA 21 |
C00043440
|
| 2475 | MTOR, FRAP, FRAP1, FRAP2, RAFT1, RAPT1 | mechanistic target of rapamycin (serine/threonine kinase) (EC:2.7.11.1) |
C00043440
|
| 8440 | NCK2, GRB4, NCKbeta | NCK adaptor protein 2 |
C00043440
|
| 25791 | NGEF, ARHGEF27, EPHEXIN | neuronal guanine nucleotide exchange factor |
C00043440
|
| 4864 | NPC1, NPC | Niemann-Pick disease, type C1 |
C00043440
|
| 4879 | NPPB, BNP | natriuretic peptide B |
C00043440
|
| 1728 | NQO1, DHQU, DIA4, DTD, NMOR1, NMORI, QR1 | NAD(P)H dehydrogenase, quinone 1 (EC:1.6.5.2) |
C00043440
|
| 2908 | NR3C1, GCCR, GCR, GR, GRL | nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
C00043440
|
| 4893 | NRAS, ALPS4, N-ras, NRAS1, NS6 | neuroblastoma RAS viral (v-ras) oncogene homolog |
C00043440
|
| 142 | PARP1, ADPRT, ADPRT_1, ADPRT1, ARTD1, PARP, PARP-1, PPOL, pADPRT-1 | poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) |
C00043440
|
| 5295 | PIK3R1, AGM7, GRB1, p85, p85-ALPHA | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
C00043440
|
| 5327 | PLAT, T-PA, TPA | plasminogen activator, tissue (EC:3.4.21.68) |
C00043440
|
| 1263 | PLK3, CNK, FNK, PRK | polo-like kinase 3 (EC:2.7.11.21) |
C00043440
|
| 10848 | PPP1R13L, IASPP, NKIP1, RAI, RAI4 | protein phosphatase 1, regulatory subunit 13 like |
C00043440
|
| 9055 | PRC1, ASE1 | protein regulator of cytokinesis 1 |
C00043440
|
| 5580 | PRKCD, MAY1, PKCD, nPKC-delta | protein kinase C, delta (EC:2.7.10.2 2.7.11.13) |
C00043440
|
| 338095 |
C00043440
|
||
| 5728 | PTEN, 10q23del, BZS, CWS1, DEC, GLM2, MHAM, MMAC1, PTEN1, TEP1 | phosphatase and tensin homolog (EC:3.1.3.67 3.1.3.16 3.1.3.48) |
C00043440
|
| 64901 | RANBP17 | RAN binding protein 17 |
C00043440
|
| 5925 | RB1, OSRC, RB, p105-Rb, pRb, pp110 | retinoblastoma 1 |
C00043440
|
| 5929 | RBBP5, RBQ3, SWD1 | retinoblastoma binding protein 5 |
C00043440
|
| 5930 | RBBP6, MY038, P2P-R, PACT, RBQ-1, SNAMA | retinoblastoma binding protein 6 |
C00043440
|
| 5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A |
C00043440
|
| 6198 | RPS6KB1, PS6K, S6K, S6K-beta-1, S6K1, STK14A, p70_S6KA, p70(S6K)-alpha, p70-S6K, p70-alpha | ribosomal protein S6 kinase, 70kDa, polypeptide 1 (EC:2.7.11.1) |
C00043440
|
| 6382 | SDC1, CD138, SDC, SYND1, syndecan | syndecan 1 |
C00043440
|
| 5054 | SERPINE1, PAI, PAI-1, PAI1, PLANH1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
C00043440
|
| 42601 |
C00043440
|
||
| 85413 | SLC22A16, CT2, FLIPT2, OAT6, OCT6, OKB1, dJ261K5.1 | solute carrier family 22 (organic cation/carnitine transporter), member 16 |
C00043440
|
| 6586 | SLIT3, MEGF5, SLIL2, SLIT1, Slit-3, slit2 | slit homolog 3 (Drosophila) |
C00043440
|
| 6609 | SMPD1, ASM, ASMASE, NPD | sphingomyelin phosphodiesterase 1, acid lysosomal (EC:3.1.4.12) |
C00043440
|
| 55512 | SMPD3, NSMASE2 | sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) (EC:3.1.4.12) |
C00043440
|
| 3431 | SP110, IFI41, IFI75, IPR1, VODI | SP110 nuclear body protein |
C00043440
|
| 6670 | SP3, SPR2 | Sp3 transcription factor |
C00043440
|
| 29114 | TAGLN3, NP22, NP24, NP25 | transgelin 3 |
C00043440
|
| 6890 | TAP1, ABC17, ABCB2, APT1, D6S114E, PSF-1, PSF1, RING4, TAP1*0102N, TAP1N | transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) |
C00043440
|
| 6891 | TAP2, ABC18, ABCB3, APT2, D6S217E, PSF-2, PSF2, RING11 | transporter 2, ATP-binding cassette, sub-family B (MDR/TAP) |
C00043440
|
| 30851 | TAX1BP3, TIP-1 | Tax1 (human T-cell leukemia virus type I) binding protein 3 |
C00043440
|
| 79853 | TM4SF20, PRO994, SLI5, TCCE518 | transmembrane 4 L six family member 20 |
C00043440
|
| 8797 | TNFRSF10A, APO2, CD261, DR4, TRAILR-1, TRAILR1 | tumor necrosis factor receptor superfamily, member 10a |
C00043440
|
| 8795 | TNFRSF10B, CD262, DR5, KILLER, KILLER/DR5, TRAIL-R2, TRAILR2, TRICK2, TRICK2A, TRICK2B, TRICKB, ZTNFR9 | tumor necrosis factor receptor superfamily, member 10b |
C00043440
|
| 8743 | TNFSF10, APO2L, Apo-2L, CD253, TL2, TRAIL | tumor necrosis factor (ligand) superfamily, member 10 |
C00043440
|
| 8744 | TNFSF9, 4-1BB-L, CD137L | tumor necrosis factor (ligand) superfamily, member 9 |
C00043440
|
| 7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00043440
|
| 9540 | TP53I3, PIG3 | tumor protein p53 inducible protein 3 |
C00043440
|
| 11257 | TP53TG1, LINC00096, NCRNA00096, P53TG1, P53TG1-D, TP53AP1 | TP53 target 1 (non-protein coding) |
C00043440
|
| 7298 | TYMS, HST422, TMS, TS | thymidylate synthetase (EC:2.1.1.45) |
C00043440
|
| 7421 | VDR, NR1I1 | vitamin D (1,25- dihydroxyvitamin D3) receptor |
C00043440
|
| 7422 | VEGFA, MVCD1, VEGF, VPF | vascular endothelial growth factor A |
C00043440
|
| 26137 | ZBTB20, DPZF, HOF, ODA-8S, ZNF288 | zinc finger and BTB domain containing 20 |
C00043440
|
| OMIM | preferred title | UniProt |
|---|---|---|
| #300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
| #100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
| #202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
| #103780 | Alcohol dependence |
P08172
P14416 P31645 |
| #614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
| #609135 | Aplastic anemia |
O14746
|
| #614473 | Arterial calcification, generalized, of infancy, 2; gaci2 |
O95255
|
| #614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
| #601816 | Bilirubin, serum level of, quantitative trait locus 1; biliqtl1 |
P22309
|
| #614490 | Blood group, junior system; jr |
Q9UNQ0
|
| #210900 | Bloom syndrome; blm |
P54132
|
| #602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
| #114480 | Breast cancer |
P38398
|
| #604370 | Breast-ovarian cancer, familial, susceptibility to, 1; brovca1 |
P38398
|
| #300615 | Brunner syndrome |
P21397
|
| #605479 | Cholestasis, benign recurrent intrahepatic, 2; bric2 |
O95342
|
| #601847 | Cholestasis, progressive familial intrahepatic, 2; pfic2 |
O95342
|
| #300882 | Cornelia de lange syndrome 5; cdls5 |
Q9BY41
|
| #218800 | Crigler-najjar syndrome, type i |
P22309
|
| #606785 | Crigler-najjar syndrome, type ii |
P22309
|
| #162800 | Cyclic neutropenia |
P08246
|
| #612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
| #609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
| #608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
| #237500 | Dubin-johnson syndrome; djs |
Q92887
|
| #613989 | Dyskeratosis congenita, autosomal dominant, 2; dkca2 |
O14746
|
| #133239 | Esophageal cancer |
P04637
|
| #615363 | Estrogen resistance; estrr |
P03372
|
| #600274 | Frontotemporal dementia; ftd |
P10636
|
| #613659 | Gastric cancer |
P04626
|
| #137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
| #231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
| #143500 | Gilbert syndrome |
P22309
|
| #137800 | Glioma susceptibility 1; glm1 |
P04626
|
| #605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
| #609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
| #143100 | Huntington disease; hd |
P42858
|
| #237900 | Hyperbilirubinemia, transient familial neonatal; hblrtfn |
P22309
|
| #145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
| #612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
| #603932 | Intervertebral disc disease; idd |
P14780
|
| #151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
| #613688 | Long qt syndrome 2; lqt2 |
Q12809
|
| #211980 | Lung cancer |
P00533
P04626 P04637 |
| #608516 | Major depressive disorder; mdd |
P08172
|
| #615134 | Melanoma, cutaneous malignant, susceptibility to, 9; cmm9 |
O14746
|
| #300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
| %300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
| #300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
| #613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
| #259600 | Multicentric osteolysis, nodulosis, and arthropathy; mona |
P08253
|
| #131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
| #126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
| #607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
| #159900 | Myoclonic dystonia |
P14416
|
| #202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
| #601665 | Obesity |
P32245
|
| #164230 | Obsessive-compulsive disorder; ocd |
P31645
|
| #604715 | Orthostatic intolerance |
P23975
|
| #259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
| #167000 | Ovarian cancer |
P04626
P38398 |
| #614320 | Pancreatic cancer, susceptibility to, 4; pnca4 |
P38398
|
| #167800 | Pancreatitis, hereditary; pctt |
P07477
|
| #260500 | Papilloma of choroid plexus; cpp |
P04637
|
| #260540 | Parkinson-dementia syndrome |
P10636
|
| #613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
| #172700 | Pick disease of brain |
P10636
|
| #601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
| #264800 | Pseudoxanthoma elasticum; pxe |
O95255
|
| #614742 | Pulmonary fibrosis and/or bone marrow failure, telomere-related, 1; pfbmft1 |
O14746
|
| #178500 | Pulmonary fibrosis, idiopathic; ipf |
O14746
|
| #607276 | Resting heart rate, variation in |
P08588
|
| #608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
| #609620 | Short qt syndrome 1; sqt1 |
Q12809
|
| #253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
| #253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
| #253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
| #271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
| #183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
| #607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
| #275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
| #601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
| #188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
| #274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
| #145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
| #190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
| #138900 | Uric acid concentration, serum, quantitative trait locus 1; uaqtl1 |
Q9UNQ0
|
| #277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
| #610379 | West nile virus, susceptibility to |
P51681
|
| #309585 | Wilson-turner x-linked mental retardation syndrome; wts |
Q9BY41
|
| #112100 | Yt blood group antigen |
P22303
|
| KEGG | name | UniProt |
|---|---|---|
| H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
| H00034 | Carcinoid |
O00255
(related)
|
| H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
| H00246 | Primary hyperparathyroidism |
O00255
(related)
|
| H01102 | Pituitary adenomas |
O00255
(related)
|
| H00764 | Cri du chat syndrome |
O14746
(related)
|
| H01132 | Aplastic anemia (AA) |
O14746
(related)
|
| H01299 | Idiopathic pulmonary fibrosis |
O14746
(related)
|
| H00022 | Bladder cancer |
O14746
(marker)
P00533 (related) P04626 (related) P04637 (related) |
| H00024 | Prostate cancer |
O14746
(marker)
|
| H00560 | Pseudoxanthoma elasticum |
O95255
(related)
|
| H00624 | Familial cholestasis |
O95342
(related)
|
| H00016 | Oral cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
| H00017 | Esophageal cancer |
P00533
(related)
P04637 (related) P04637 (marker) P35354 (related) |
| H00018 | Gastric cancer |
P00533
(related)
P04626 (related) P04637 (related) |
| H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) P04637 (related) P08253 (related) |
| H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
| H00042 | Glioma |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
| H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
| H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
| H00436 | Osteopetrosis |
P00918
(related)
|
| H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) P04637 (related) Q92731 (marker) |
| H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
| H00019 | Pancreatic cancer |
P04626
(related)
P04637 (related) P04637 (marker) |
| H00027 | Ovarian cancer |
P04626
(related)
P04637 (related) P38398 (related) |
| H00031 | Breast cancer |
P04626
(related)
P04626 (marker) P04637 (related) P38398 (related) |
| H00046 | Cholangiocarcinoma |
P04626
(related)
P04637 (related) P35354 (related) |
| H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
Q01196 (related) |
| H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
| H00006 | Hairy-cell leukemia |
P04637
(related)
|
| H00008 | Burkitt lymphoma |
P04637
(related)
|
| H00009 | Adult T-cell leukemia |
P04637
(related)
|
| H00010 | Multiple myeloma |
P04637
(related)
|
| H00013 | Small cell lung cancer |
P04637
(related)
|
| H00014 | Non-small cell lung cancer |
P04637
(related)
|
| H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
| H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
| H00025 | Penile cancer |
P04637
(related)
P04637 (marker) P08253 (related) P14780 (related) P35354 (related) |
| H00029 | Vulvar cancer |
P04637
(related)
|
| H00032 | Thyroid cancer |
P04637
(related)
|
| H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
| H00038 | Malignant melanoma |
P04637
(related)
|
| H00039 | Basal cell carcinoma |
P04637
(related)
|
| H00040 | Squamous cell carcinoma |
P04637
(related)
|
| H00041 | Kaposi's sarcoma |
P04637
(related)
|
| H00044 | Cancer of the anal canal |
P04637
(related)
|
| H00047 | Gallbladder cancer |
P04637
(related)
|
| H00048 | Hepatocellular carcinoma |
P04637
(related)
|
| H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
| H01007 | Choroid plexus papilloma |
P04637
(related)
|
| H00021 | Renal cell carcinoma |
P04637
(marker)
|
| H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
| H00933 | Hereditary pancreatitis |
P07477
(related)
|
| H00079 | Asthma |
P07550
(related)
|
| H00100 | Neutropenic disorders |
P08246
(related)
|
| H00472 | Torg-Winchester syndrome |
P08253
(related)
|
| H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
| H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
| H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
| H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
| H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
| H00342 | Tuberculosis |
P11473
(related)
|
| H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
| H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
| H01205 | Coumarin resistance |
P11712
(related)
|
| H00479 | Metaphyseal dysplasias |
P14780
(related)
|
| H00548 | Brunner syndrome |
P21397
(related)
|
| H00208 | Hyperbilirubinemia |
P22309
(related)
Q92887 (related) |
| H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
| H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
| H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
| H00059 | Huntington's disease (HD) |
P42858
(related)
|
| H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
Q99714 (related) |
| H00094 | DNA repair defects |
P54132
(related)
|
| H00296 | Defects in RecQ helicases |
P54132
(related)
|
| H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) Q03164 (related) Q03164 (marker) |
| H00003 | Acute myeloid leukemia (AML) |
Q01196
(related)
Q01196 (marker) Q13951 (marker) |
| H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
| H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
| H00720 | Long QT syndrome |
Q12809
(related)
|
| H00725 | Short QT syndrome |
Q12809
(related)
|
| H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
|
| H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
Q9NUW8 (related) |
| H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
| H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
| MESH or OMIM | name |
KNApSAcK
metabolite |
|---|---|---|
| D000014 | Abnormalities, Drug-Induced |
C00043440
|
| D000230 | Adenocarcinoma |
C00043440
|
| D000740 | Anemia |
C00043440
|
| D000741 | Anemia, Aplastic |
C00043440
|
| D001145 | Arrhythmias, Cardiac |
C00043440
|
| D001201 | Ascites |
C00043440
|
| D001416 | Back Pain |
C00043440
|
| D001847 | Bone Diseases |
C00043440
|
| D001855 | Bone Marrow Diseases |
C00043440
|
| D001929 | Brain Edema |
C00043440
|
| D001932 | Brain Neoplasms |
C00043440
|
| D002051 | Burkitt Lymphoma |
C00043440
|
| D006528 | Carcinoma, Hepatocellular |
C00043440
|
| D009202 | Cardiomyopathies |
C00043440
|
| D002471 | Cell Transformation, Neoplastic |
C00043440
|
| D002493 | Central Nervous System Diseases |
C00043440
|
| D002526 | Cerebellar Diseases |
C00043440
|
| D002543 | Cerebral Hemorrhage |
C00043440
|
| D002637 | Chest Pain |
C00043440
|
| D002779 | Cholestasis |
C00043440
|
| D003967 | Diarrhea |
C00043440
|
| D004195 | Disease Models, Animal |
C00043440
|
| D004342 | Drug Hypersensitivity |
C00043440
|
| D056486 | Drug-Induced Liver Injury |
C00043440
|
| D064420 | Drug-Related Side Effects and Adverse Reactions |
C00043440
|
| D004719 | Endomyocardial Fibrosis |
C00043440
|
| D004890 | Erythema |
C00043440
|
| D005334 | Fever |
C00043440
|
| D018226 | Fibroadenoma |
C00043440
|
| D005355 | Fibrosis |
C00043440
|
| D005921 | Glomerulonephritis |
C00043440
|
| D005923 | Glomerulosclerosis, Focal Segmental |
C00043440
|
| D006261 | Headache |
C00043440
|
| D006331 | Heart Diseases |
C00043440
|
| D006333 | Heart Failure |
C00043440
|
| D006402 | Hematologic Diseases |
C00043440
|
| D019337 | Hematologic Neoplasms |
C00043440
|
| D006470 | Hemorrhage |
C00043440
|
| D006504 | Hepatic Veno-Occlusive Disease |
C00043440
|
| D006937 | Hypercholesterolemia |
C00043440
|
| D006949 | Hyperlipidemias |
C00043440
|
| D054559 | Hyperphosphatemia |
C00043440
|
| D015228 | Hypertriglyceridemia |
C00043440
|
| D007019 | Hypoproteinemia |
C00043440
|
| D007022 | Hypotension |
C00043440
|
| D007235 | Infant, Premature, Diseases |
C00043440
|
| D007239 | Infection |
C00043440
|
| D007674 | Kidney Diseases |
C00043440
|
| D007676 | Kidney Failure, Chronic |
C00043440
|
| D007938 | Leukemia |
C00043440
|
| D004915 | Leukemia, Erythroblastic, Acute |
C00043440
|
| D007942 | Leukemia, Experimental |
C00043440
|
| D015470 | Leukemia, Myeloid, Acute |
C00043440
|
| D007952 | Leukemia, Plasma Cell |
C00043440
|
| D015473 | Leukemia, Promyelocytic, Acute |
C00043440
|
| D056784 | Leukoencephalopathies |
C00043440
|
| D007970 | Leukopenia |
C00043440
|
| D008107 | Liver Diseases |
C00043440
|
| D017093 | Liver Failure |
C00043440
|
| D008228 | Lymphoma, Non-Hodgkin |
C00043440
|
| D015674 | Mammary Neoplasms, Animal |
C00043440
|
| D028361 | Mitochondrial Diseases |
C00043440
|
| D052016 | Mucositis |
C00043440
|
| D009205 | Myocarditis |
C00043440
|
| D009336 | Necrosis |
C00043440
|
| D009369 | Neoplasms |
C00043440
|
| D009401 | Nephrosis |
C00043440
|
| D009404 | Nephrotic Syndrome |
C00043440
|
| D009422 | Nervous System Diseases |
C00043440
|
| D009503 | Neutropenia |
C00043440
|
| D010182 | Pancreatic Diseases |
C00043440
|
| D010292 | Paresthesia |
C00043440
|
| D010493 | Pericarditis |
C00043440
|
| D010523 | Peripheral Nervous System Diseases |
C00043440
|
| D011014 | Pneumonia |
C00043440
|
| D015452 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma |
C00043440
|
| D054198 | Precursor Cell Lymphoblastic Leukemia-Lymphoma |
C00043440
|
| D054218 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma |
C00043440
|
| D011252 | Pregnancy Complications, Neoplastic |
C00043440
|
| D011507 | Proteinuria |
C00043440
|
| D012640 | Seizures |
C00043440
|
| D012770 | Shock, Cardiogenic |
C00043440
|
| D012804 | Sick Sinus Syndrome |
C00043440
|
| D013280 | Stomatitis |
C00043440
|
| D013616 | Tachycardia, Sinus |
C00043440
|
| D024801 | Tauopathies |
C00043440
|
| D013921 | Thrombocytopenia |
C00043440
|
| D013927 | Thrombosis |
C00043440
|
| D013952 | Thymus Hyperplasia |
C00043440
|
| D016171 | Torsades de Pointes |
C00043440
|
| D014202 | Tremor |
C00043440
|
| D014652 | Vascular Diseases |
C00043440
|
| D018754 | Ventricular Dysfunction |
C00043440
|
| D018487 | Ventricular Dysfunction, Left |
C00043440
|
| D015431 | Weight Loss |
C00043440
|